These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23943291)

  • 1. Thirty down, only ten to go?! Awareness and influence of a 10-year time frame in TTO.
    van Nooten FE; Koolman X; Busschbach JJ; Brouwer WB
    Qual Life Res; 2014 Mar; 23(2):377-84. PubMed ID: 23943291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of subjective life expectancy on health state valuations using a 10 year TTO.
    van Nooten FE; Koolman X; Brouwer WB
    Health Econ; 2009 May; 18(5):549-58. PubMed ID: 18702082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Married with children" the influence of significant others in TTO exercises.
    van Nooten FE; van Exel NJ; Koolman X; Brouwer WB
    Health Qual Life Outcomes; 2015 Jul; 13():94. PubMed ID: 26135391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A (Latent) Class of Their Own: Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises.
    van Nooten FE; Houghton K; van Exel J; van Agthoven M; Brouwer WBF; Stull DE
    Value Health; 2017 Dec; 20(10):1403-1410. PubMed ID: 29241900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the EQ-5D reflect lost earnings?
    Tilling C; Krol M; Tsuchiya A; Brazier J; Exel Jv; Brouwer W
    Pharmacoeconomics; 2012 Jan; 30(1):47-61. PubMed ID: 22066754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Back to the future": Influence of beliefs regarding the future on TTO answers.
    van Nooten FE; van Exel NJ; Eriksson D; Brouwer WB
    Health Qual Life Outcomes; 2016 Jan; 14():4. PubMed ID: 26753687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuations.
    Al Sayah F; Mladenovic A; Gaebel K; Xie F; Johnson JA
    Qual Life Res; 2016 Jan; 25(1):35-43. PubMed ID: 26216584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of patients' subjective life expectancy on time tradeoff valuations.
    Heintz E; Krol M; Levin LÅ
    Med Decis Making; 2013 Feb; 33(2):261-70. PubMed ID: 23268838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study.
    Sayah FA; Bansback N; Bryan S; Ohinmaa A; Poissant L; Pullenayegum E; Xie F; Johnson JA
    Qual Life Res; 2016 Jul; 25(7):1679-85. PubMed ID: 26659899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenced from the start: anchoring bias in time trade-off valuations.
    Augestad LA; Stavem K; Kristiansen IS; Samuelsen CH; Rand-Hendriksen K
    Qual Life Res; 2016 Sep; 25(9):2179-91. PubMed ID: 27016943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construct validity of the interview time trade-off and computer time trade-off in patients with rheumatoid arthritis: a cross-sectional observational pilot study.
    Buitinga L; Braakman-Jansen LM; Taal E; van de Laar MA
    BMC Musculoskelet Disord; 2012 Jun; 13():112. PubMed ID: 22730908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inconsistencies in TTO and VAS values for EQ-5D health states.
    Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
    Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expect Nothing: The (Lack of) Influence of Subjective Life Expectancy on Valuation of Child Health States.
    Lipman SA
    Front Health Serv; 2022; 2():803109. PubMed ID: 36925864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in EQ-5D-3L health state valuations among patients with musculoskeletal diseases, health care professionals and healthy volunteers.
    Schwalm A; Feng YS; Moock J; Kohlmann T
    Eur J Health Econ; 2015 Nov; 16(8):865-77. PubMed ID: 25283996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.
    Rand-Hendriksen K; Augestad LA
    Value Health; 2012; 15(5):777-82. PubMed ID: 22867789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs.
    Péntek M; Brodszky V; Biró Z; Kölkedi Z; Dunai Á; Németh J; Baji P; Rencz F; Gulácsi L; Resch MD
    BMC Geriatr; 2017 Oct; 17(1):233. PubMed ID: 29017463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
    Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
    Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
    Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
    Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.